References
- International Schizophrenia Consortium; Purcell SM, Wray NR, Stone JL et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature460(7256) , 748–752 (2009).
- Glatt SJ , EverallIP, KremenWS et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc. Natl Acad. Sci. USA 102(43) , 15533–15538 (2005).
- Abdolmaleky HM , ChengKH, RussoA et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134(1) , 60–66 (2005).
- Grayson DR , JiaX, ChenY et al. Reelin promoter hyper-methylation in schizophrenia. Proc. Natl Acad. Sci. USA 102(26) , 9341–9346 (2005).
- Iwamoto K , BundoM, YamadaK et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 25(22) , 5376–5381 (2005).
- Abdolmaleky HM , YaqubiS, PapageorgisP et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr. Res. 129(2–3) , 183–190 (2011).
- Tolosa A , SanjuánJ, DagnallAM et al. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies. BMC Med. Genet.11 , 114, 1–8 (2010).
- Abdolmaleky HM , ChengKH, FaraoneSV et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15(21) , 3132–3145 (2006).
- Mill J , TangT, KaminskyZ et al. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82(3) , 696–711 (2008).
- Ghadirivasfi M , NohesaraS, AhmadkhanihaHR et al. Hypomethylation of serotonin receptor type-2 (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J. Med. Genet. B Neuropsychiatr. Genet. 156(5) , 536–545 (2011).
- Nohesara S , GhadirivasfiM, MostafaviS et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J. Psychiatr. Res. 45(11) , 1432–1438 (2011).
- Abdolmaleky HM , ZhouJR, ThiagalingamS et al. Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics. Pharmacogenomics 9(12) , 1809–1823 (2008).
- Issidorides MR , StefanisCN, VarsouE et al. Altered chromatin ultrastructure in neutrophils of schizophrenics. Nature 258(5536) , 612–614 (1975).
- Stefanis CN , IssidoridesMR. Histochemical changes in the blood cells of schizophrenic patients under pimozide treatment. Biol. Psychiatry11(1) , 53–68 (1976).
- Akbarian S , RuehlMG, BlivenE et al. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 62(8) , 829–840 (2005).
- Sharma RP , RosenC, KartanS et al. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr. Res. 88 , 227–231 (2006).
- Huang HS , MatevossianA, WhittleC et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukaemia 1-regulated histone methylation at GABAergic gene promoters. J. Neurosci. 27(42) , 11254–11262 (2007).
- Gavin DP , RosenC, ChaseK et al. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J. Psychiatry Neurosci. 34(3) , 232–237 (2009).
- Guidotti A , DongE, KundakovicM et al. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol. Sci. 30(2) , 55–60 (2009).
- Sharma RP , GraysonDR, GavinDP. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr. Res.98(1–3) , 111–117 (2008).
- Benes FM , LimB, MatzilevichD et al. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl Acad. Sci. USA 104(24) , 10164–10169 (2007).
- Gavin DP , KartanS, ChaseK et al. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophr. Res. 103(1–3) , 330–332 (2008).
- Santarelli DM , BeveridgeNJ, TooneyPA et al. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 69(2) , 180–187 (2011).
- Beveridge NJ , GardinerE, CarrollAP et al. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 15(12) , 1176–1189 (2010).
- Beveridge NJ , TooneyPA, CarrollAP et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 17(8) , 1156–1168 (2008).
- Kim AH , ReimersM, MaherB et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 124(1–3) , 183–191 (2010).
- Zhu Y , KalbfleischT, BrennanMD et al. A microRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophr. Res. 109(1–3) , 86–89 (2009).
- Mellios N , GaldzickaM, GinnsE et al. Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr. Bull. doi:10.1093/schbul/sbq091 (2010) (Epub ahead of print).
- Xu Y , LiF, ZhangB et al. MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. Schizophr. Res. 119(1–3) , 219–227 (2010).
- Moreau MP , BruseSE, David-RusR et al. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69(2) , 188–193 (2011).